Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
IPCALAB
IPCALAB

Ipca Laboratories Ltd.

NSE: IPCALAB
BSE: 524494
Sector: Healthcare
Industry: Pharmaceuticals
1,953.30+53.5 (+2.82%)
23 Oct, 12:00 AM

Stock Scores

Quality Score

92.1 / 100

Value Score

22.0 / 100

Price Momentum Score

96.4 / 100

QVM Score

89.4 / 100

Key Metrics

Market Cap
49556.00
P/E (TTM)
37.83
P/B
6.15
P/S (TTM)
4.89
EV/EBITDA
22.03
CAPE (5Y)
65.58
ROE (TTM)
15.20
ROCE (TTM)
16.18
ROA (TTM)
9.46
Avg 3Y ROE
11.77
Earnings 3Y CAGR
38.68
Sales 3Y CAGR
17.47
Sales 5Y CAGR
13.18
Debt/Equity
0.10
Consensus TP
2007.00
Strong Buy %
43.75
Promoter Holding
44.72
Pledged %
0.00

Share Price

Track Ipca Laboratories Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 6.59 %
Low
1,791.8
High
1,979.8
1 Month returns: -0.47 %
Low
1,791.8
High
2,020.0
1 Year returns: 53.16 %
Low
1,251.6
High
2,039.3
3 Year CAGR: 25.11 %
Low
960.0
High
2,039.3
5 Year CAGR: 11.38 %
Low
669.8
High
2,039.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for Ipca Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Ipca Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Ipca Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Ipca Laboratories Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of Ipca Laboratories Ltd.?
The current share price of Ipca Laboratories Ltd. is ₹ 1,953.30 as of 23 Oct 2026.
What is the market capitalisation of Ipca Laboratories Ltd.?
The market capitalisation of Ipca Laboratories Ltd. stands at ₹ 49,556.00 Cr.
What is the PE ratio of Ipca Laboratories Ltd.?
The Price-to-Earnings (PE) ratio of Ipca Laboratories Ltd. is 37.83 as of the latest trailing twelve months data.
What is the ROE and ROCE of Ipca Laboratories Ltd.?
Ipca Laboratories Ltd. has a Return on Equity (ROE) of 15.20% and a Return on Capital Employed (ROCE) of 16.18% as per the latest financial reports.
What is the 52-week high and low of Ipca Laboratories Ltd.?
The 52-week high of Ipca Laboratories Ltd. is - and the 52-week low is -.
What is the dividend yield of Ipca Laboratories Ltd.?
The dividend yield of Ipca Laboratories Ltd. is 0.31% based on the current market price.
What is the FII and DII holding in Ipca Laboratories Ltd.?
Foreign Institutional Investors (FII) hold 11.52%, Domestic Institutional Investors (DII) hold 35.83% and retail/public investors hold 6.77% of Ipca Laboratories Ltd. shares.
What sector does Ipca Laboratories Ltd. belong to?
Ipca Laboratories Ltd. operates in the Healthcare sector. 75% of analysts have a Buy or Strong Buy rating on Ipca Laboratories Ltd. with a consensus target price of ₹ 2,007.00, implying 2.75% upside from current levels.
What is the beta of Ipca Laboratories Ltd.?
The beta of Ipca Laboratories Ltd. is 0.06, indicating its price volatility relative to the broader market. Over the past 1 year, Ipca Laboratories Ltd. has delivered an absolute return of 50.31%.
What is the RSI of Ipca Laboratories Ltd.?
The 14-day Relative Strength Index (RSI) of Ipca Laboratories Ltd. is 54.91, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.